In HGSOC, GATA3 is highly expressed and contributes to poor clinical outcomes by promoting tumor proliferation, migration, angiogenesis, and resistance to chemotherapy, particularly in cases with mutant TP53 (80). The gene discussed is TP53; the disease is neoplasm.